Everence Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $704K | Buy |
|
|||||
|
2025
Q2 | $542K | Sell |
|
|||||
|
2025
Q1 | $813K | Buy |
|
|||||
|
2024
Q4 | $897K | Sell |
|
|||||
|
2024
Q3 | $1.37M | Buy |
|
|||||
|
2024
Q2 | $722 | Hold |
|
|||||
|
2024
Q1 | $786 | Hold |
|
|||||
|
2023
Q4 | $704K | Sell |
|
|||||
|
2023
Q3 | $893 | Hold |
|
|||||
|
2023
Q2 | $1.12M | Hold |
|
|||||
|
2023
Q1 | $1.11K | Hold |
|
|||||
|
2022
Q4 | $1.08K | Buy |
|
|||||
|
2022
Q3 | $358K | Sell |
|
|||||
|
2022
Q2 | $1.44M | Buy |
|
|||||
|
2022
Q1 | $1.41M | Hold |
|
|||||
|
2021
Q4 | $1.48M | Hold |
|
|||||
|
2021
Q3 | $1.5M | Hold |
|
|||||
|
2021
Q2 | $1.17M | Hold |
|
|||||
|
2021
Q1 | $988K | Hold |
|
|||||
|
2020
Q4 | $1.02M | Buy |
|
|||||
|
2020
Q3 | $800K | Buy |
|